Vipul Patel

CEO/Managing Director at Perite PharmaSys Inc.

BRAMPTON, Canada

An accomplished senior executive with about 3 decades of experience across various industries with a focus on increasing sustainable profitability through business turnaround strategies. A proven track record of strong operations management executed through the development of strategies that supported key business and financial objectives. With focus towards optimizing cost is one of the key mantras for success and this came from standardization, harmonization and centralization of processes to make it work better, faster and leaner. Resourceful problem solver who thrives on translating complex data into metric-based, actionable analytics. A respected leader, known for building highly effective and motivated management teams through ongoing development, coaching and mentoring. Adept at quickly getting to business issues and driving operational change. Able to evolve structure from legacy owner to a corporate team platform.
Self-starter, Self-motivated professional exhibiting high ethics, competence and confidence underscored by a personal commitment to outstanding professional performance.
Lead the company to coveted award by Deloitte, CIBC Bank etc "Canada's Best Managed Companies 2019, 2020,2021,2022
Visionary leader with over 30 years of experience in global supply chain management within the pharmaceutical industry, recognized for propelling operational excellence, integrating cutting-edge technologies, and enhancing global compliance. My strategic initiatives have consistently driven cost reductions, improving product costs by 8%-10%, and achieving inventory variances as low as 0.02%. These efforts significantly contributed to earning distinctions such as Canada’s Best Managed Companies.
My career evolution spans from operations and supply chain specialist to a seasoned business management executive. I have spearheaded supply chain initiatives that supported over US $2 billion in annual net revenues, managing significant P&L responsibilities. My strategic leadership has not only consistently delivered cost reductions but also improved on-time, in-full (OTIF) delivery metrics by reducing order turnaround times from 96 to 24 hours, directly enhancing customer satisfaction and service deliverability.
In roles such as Chief Operating Officer and Vice President of North American Operations, I have excelled in performance management, strategic cost management, and comprehensive business planning. My expertise in M&A leadership, coupled with strong capabilities in IT systems integration and vendor management, underscores a proven track record of fostering operational excellence and robust business growth.
Praised for my emotional maturity and strong negotiation skills, I maintain a balanced approach in complex scenarios, ensuring fair and effective resolutions. My profound knowledge in IT and SAP, combined with a knack for innovative process improvements, has been crucial in driving companies through significant operational transformations. These transformations have led to substantial financial gains, including a multi-million-dollar reduction in Failure to Supply (FTS) costs and maintaining distribution cost per unit at pre-COVID levels despite an exponential increase in labor and freight costs.
This summary emphasizes my ability to lead strategic changes that enhance business operations and generate substantial growth in highly competitive environments, making me a pivotal leader in the pharmaceutical sector.

Available For: Consulting
Travels From: Toronto